Riggs Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9
Closed -$748 518
2025
Q2
$748 Hold
9
﹤0.01% 799
2025
Q1
$756 Hold
9
﹤0.01% 518
2024
Q4
$837 Hold
9
﹤0.01% 474
2024
Q3
$837 Hold
9
﹤0.01% 468
2024
Q2
$741 Hold
9
﹤0.01% 484
2024
Q1
$598 Buy
+9
New +$555 ﹤0.01% 501

Other funds holding LMAT

Riggs Asset Management's LMAT Position: Q3 2025 in Review

Riggs Asset Management sold out of LeMaitre Vascular (LMAT) in Q3 2025, closing a stake of 9 shares — an estimated $748 sold.

Riggs Asset Management first reported a position in LMAT in Q1 2024 and held it in 6 quarters. The position peaked at $837 in Q4 2024. 297 funds tracked by Wall St. Rank hold LMAT as of Q3 2025.

  • Riggs Asset Management reported no remaining LeMaitre Vascular position as of Q3 2025 after selling out during the quarter.
  • Riggs Asset Management sold 9 LeMaitre Vascular shares in Q3 2025, an estimated $748.
  • Riggs Asset Management first reported a position in LeMaitre Vascular in Q1 2024 and held it in 6 quarters.
  • Riggs Asset Management's LeMaitre Vascular position peaked at $837 in Q4 2024.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.